|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 512 10TH STREET NW |
Address2 | |
City | WASHINGTON |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 28481-12
|
||||||||
|
6. House ID# 316440000
|
TYPE OF REPORT | 8. Year | 2009 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Douglas Johnson, Legislative Director |
Date | 04/20/2009 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Contacts to House offices in support of signing letter to Speaker Pelosi et al, originated by Rep. Jim Jordan and Rep. Heath Shuler, finished on or about February 25, 2009, to urge continuation of traditional prolife provisions in upcoming appropriations bills. Contacts to House and Senate offices in support of continuation of traditional prolife provisions in appropriations bills for both FY 2009 and 2010. (continued)
Contacts to House offices in support of inclusion of traditional prolife provisions in omnibus appropriations bill for the remainder of FY 2009 (H.R. 1105). Contacts in support of two amendments submitted to Rules Committee by Rep. Chris Smith to codify MCP (SmithNJ_24.xml) and to preserve application of the Kemp-Kasten anti-coercion law to the UNFPA (SmithNJ_20.xml); neither amendment was made in order. In the Senate, supported Wicker Amt no. 607 to S. 1105, to modify the provision that would exempt UNFPA from the application of the Kemp-Kasten law; the amendment failed on the Senate floor on March 5.
Contacts in support of Coburn Amendment No. 828 to S. Con. Res. 13, the budget resolution, expressing support for the conscience rights of health care providers, failed 41-56 on April 2, 2009.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
|
Andrea |
Lyon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CIV
16. Specific lobbying issues
Contacts discussing legal aspects of bills to establish various definitions of or protections for the right to life: H.R. 227 (Rep. Paul Broun), H.R. 1822 (Rep. Trent Franks), H.R. 881 (Rep. Duncan Hunter), S. 346 (Sen. Roger Wicker).
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
|
Andrea |
Lyon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code COM
16. Specific lobbying issues
Contacts in support of S. 34 and H.R. 226, Broadcaster Freedom Act, to prevent reimposition of the so-called Fairness Doctrine.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
|
Andrea |
Lyon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FAM
16. Specific lobbying issues
Contacts with House and Senate in opposition to the "Freedom of Choice Act" (FOCA), a bill to invalidate virtually all state and federal laws and policies that in any way limit access to abortion, the reintroduction of which is anticipated sometime during the 111th Congress. Contacts to House in support of signatures to letter originated by Rep. John Boehner to President Obama urging withdrawal of previous commitment to sign the FOCA (Jan. 21 2009). (continued)
Contacts to House in support of Child Interstate Abortion Notification Act (CIANA) (H.R. 634). Consultations with Senate staff regarding possible re-introduction of the Child Custody Protection Act.
Contacts in support of S. 85 and H.R. 614, legislation to exclude certain abortion providers from funding under Title X of the Public Health Service Act.
Contacts in opposition to 74 FR 10207, DHHS rulemaking proposal to rescind a final rule (73 FR 78072) providing certain protections to health care providers who do not wish to participate in providing abortions. (NRLC supports the rule and opposes the recission.) Contacts to support signatures on letter sent to President Obama on April 3, 2009, by Reps. Fleming, Davis (Tn.), and others, opposing recission of the regulation. Contacts in opposition to H.R. 570, a bill to nullify the conscience-protection regulation. Contacts in support of S. 96, Abortion Nondiscrimination Act. Contacts in support of Coburn Amendment No. 828 to S. Con. Res. 13, the budget resolution, expressing support for the conscience rights of health care providers, failed 41-56 on April 2, 2009.
Contacts in support of H.R. 636, the Positive Alternatives Act, sponsored by Rep. Michele Bachmann.
Contacts to House advisory with respect to certain issues pertaining to repeat abortions; no legislation introduced.
Contacts generally supportive of certain titles of S. 270 and H.R. 605, Pregnant Women and Family Support Act, while not taking a position on the overall omnibus legislation at this time. Contacts expressing objections to certain components of S. 21 and H.R. 463.
Contacts in support of H.R. 649, the Ultrasound Informed Consent Act; H.R. 213, the Adoption Tax Relief Guarantee Act; and H.R. 195, the Informed Choice Act (aid for ultrasound machines for certain centers).
NRLC co-signed multi-group letter to Senator Patrick Leahy and other members of the Senate Judiciary Committee, expressing concerns regarding the records of David Ogden (nominated to be deputy attorney general), Dawn Johnsen (nominated to be assistant attorney general for the Office of Legal Counsel), and Thomas Perrelli (nominated to be associate attorney general), sent early February 2009. Subsequent contacts in opposition to the confirmation of Dawn Johnsen, including NRLC letter to Senate sent March 27, 2009.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
|
Andrea |
Lyon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOR
16. Specific lobbying issues
Contacts in support of Martinez amendment no. 65 to H.R. 2 to codify the pro-life Mexico City Policy; amendment failed January 28, 2009). Contacts in support of H.R. 708, sponsored by Rep. Chris Smith, to codify key aspects of the Mexico City Policy. (continued)
Contacts in support of H.R. 1967, sponsored by Rep. F. James Sensenbrenner, to prohibit funding of organizations that support or participate in the management of programs that include coercive abortion or involuntary sterilization.
Contacts in opposition to ratification of the Convention for the Elimination of All Forms of Discrimination Against Women (CEDAW), including a letter to Senate dated March 25, 2009. Contacts in opposition to H. Res. 22, a resolution that urges the Senate to ratify the CEDAW.
Contacts to House expressing general concerns about abortion-related issues that may arise during anticipated reauthorization/rewrite of the Foreign Assistance Act.
Contacts to House offices in support of inclusion of traditional prolife provisions in omnibus appropriations bill for the remainder of FY 2009 (H.R. 1105). Contacts in support of two amendments submitted to Rules Committee by Rep. Chris Smith to codify MCP (SmithNJ_24.xml) and to preserve application of the Kemp-Kasten anti-coercion law to the UNFPA (SmithNJ_20.xml); neither amendment was made in order. In the Senate, supported Wicker Amt no. 607 to S. 1105, to modify the provision that would exempt UNFPA from the application of the Kemp-Kasten law; the amendment failed on the Senate floor on March 5.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
|
Andrea |
Lyon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Contacts in support of exclusion of abortion from anticipated health care reform legislation currently under development, including contacts providing analysis of abortion-related implications of S. 391, sponsored by Senator Wyden. Contacts in support of Hatch Amendment (Senate Amendment No. 80) to SCHIP reauthorization legislation (H.R. 2), to codify unborn child regulation; amendment failed January 29, 2009. (continued)
Contacts responding to inquiries regarding the nomination of Kathleen Sebelius as secretary of Health and Human Services.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
|
Andrea |
Lyon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
On Senator Max Baucus's "Call to Action: Health Reform 2009" [commonly known as the "Baucus White Paper on Health Reform"], Healthy Americans Act (S. 391), and health care reform generally, opposed rationing of health care, supported addition of variable withhold financing method to avoid rationing. (continued)
On American Recovery and Reinvestment Act of 2009 (H.R. 1), answered inquiries to provide assurances we were not opposing the bill. Attempted to discourage the use of phrases in Title XXX - HEALTH INFORMATION TECHNOLOGY AND QUALITY, Sec. 3001: "inappropriate care", "reducing health disparities" in order to alleviate the potential for "quality of life" judgments.
Discussions generally on potential "Comparative Effectiveness" legislation, regarding comparative effectiveness standards in Medicare, worked to ensure that patient's competence, age, expected length of life, present or predicted disability, degree of medical dependency, or quality of life will not be used as the basis for denial of Medicare benefits to patients against their wishes.
Discussions regarding a possible federal bill to create a national registry for advanced directives (no such legislation introduced).
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Thomas (Burke) |
Balch |
|
|
|
Jennifer |
Popik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LAW
16. Specific lobbying issues
Assisted Senate offices in developing questions regarding the views of Ronald Weich, nominated as assistant attorney general, regarding enforcement of 18 U.S.C. 1841, in view of testimony he presented on his own behalf strongly opposing this legislation when it was under consideration in 1999 and 2000.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Contacts (including March 31, 2009 letter to members of the House of Representatives) in opposition to anticipated authorization legislation to allow or require federal funding of research that requires killing of human embryos and/or creation of human embryos by cloning, and urging continuation of Dickey-Wicker embryo-protection language on FY 2010 appropriations bill for Labor-HHS. (continued)
Contacts in support of H.R. 877, Patients First Act, sponsored by Reps. Forbes and Lipinski (to promote federal funding of ethical forms of stem cell research), and H.R. 1050, the Human Cloning Prohibition Act, sponsored by Reps. Bart Stupak and Zach Wamp, to prohibit the creation of embryos of the species homo sapiens by cloning.
Contacts in opposition to H.R. 872 and H.R. 873, sponsored by Reps. DeGette and Castle, and S. 487, sponsored by Senators Harkin and Specter, bills to authorize federal funding of embryo-destructive research, including distribution of letter dated March 31, 2009.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
|
Andrea |
Lyon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
On Senator Max Baucus's "Call to Action: Health Reform 2009" [commonly known as the "Baucus White Paper on Health Reform"], Healthy Americans Act (S. 391), and health care reform generally, opposed rationing of health care, supported addition of variable withhold financing method to avoid rationing. (continued)
On American Recovery and Reinvestment Act of 2009 (H.R. 1), answered inquiries to provide assurances we were not opposing the bill. Attempted to discourage the use of phrases in Title XXX - HEALTH INFORMATION TECHNOLOGY AND QUALITY, Sec. 3001: "inappropriate care", "reducing health disparities" in order to alleviate the potential for "quality of life" judgments.
Discussions generally on potential "Comparative Effectiveness" legislation, regarding comparative effectiveness standards in Medicare, worked to ensure that patient's competence, age, expected length of life, present or predicted disability, degree of medical dependency, or quality of life will not be used as the basis for denial of Medicare benefits to patients against their wishes.
Discussions regarding a possible federal bill to create a national registry for advanced directives (no such legislation introduced).
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Thomas (Burke) |
Balch |
|
|
|
Jennifer |
Popik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SCI
16. Specific lobbying issues
Contacts (including March 31, 2009 letter to members of the House of Representatives) in opposition to anticipated authorization legislation to allow or require federal funding of research that requires killing of human embryos and/or creation of human embryos by cloning, and urging continuation of Dickey-Wicker embryo-protection language on FY 2010 appropriations bill for Labor-HHS. (continued)
Contacts in support of H.R. 877, Patients First Act, sponsored by Reps. Forbes and Lipinski (to promote federal funding of ethical forms of stem cell research), and H.R. 1050, the Human Cloning Prohibition Act, sponsored by Reps. Bart Stupak and Zach Wamp, to prohibit the creation of embryos of the species homo sapiens by cloning.
Contacts in opposition to H.R. 872 and H.R. 873, sponsored by Reps. DeGette and Castle, and S. 487, sponsored by Senators Harkin and Specter, bills to authorize federal funding of embryo-destructive research, including distribution of letter dated March 31, 2009.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
|
Andrea |
Lyon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
CON |
IND |
|
|
|
|
|
|
|
GOV |
INS |
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |